FDA Approves Casgevy to Treat Beta-Thalassemia
Casgevy is the first CRISPR-based medicine to be approved for use in the United States
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Casgevy is the first CRISPR-based medicine to be approved for use in the United States
Only registered members have full access to PracticeUpdate content.